332 related articles for article (PubMed ID: 29713249)
1. Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial.
Fayh APT; Borges K; Cunha GS; Krause M; Rocha R; de Bittencourt PIH; Moreira JCF; Friedman R; da Silva Rossato J; Fernandes JR; Reischak-Oliveira A
J Int Soc Sports Nutr; 2018; 15():18. PubMed ID: 29713249
[TBL] [Abstract][Full Text] [Related]
2. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.
Asemi Z; Soleimani A; Shakeri H; Mazroii N; Esmaillzadeh A
Int Urol Nephrol; 2016 Nov; 48(11):1887-1895. PubMed ID: 27554670
[TBL] [Abstract][Full Text] [Related]
3. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
4. Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study.
Bloomer RJ; Larson DE; Fisher-Wellman KH; Galpin AJ; Schilling BK
Lipids Health Dis; 2009 Aug; 8():36. PubMed ID: 19691834
[TBL] [Abstract][Full Text] [Related]
5. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.
Mori TA; Woodman RJ; Burke V; Puddey IB; Croft KD; Beilin LJ
Free Radic Biol Med; 2003 Oct; 35(7):772-81. PubMed ID: 14583341
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 Fatty Acid Supplementation is Associated With Oxidative Stress and Dyslipidemia, but Does not Contribute to Better Lipid and Oxidative Status on Hemodialysis Patients.
de Mattos AM; da Costa JAC; Jordão Júnior AA; Chiarello PG
J Ren Nutr; 2017 Sep; 27(5):333-339. PubMed ID: 28434760
[TBL] [Abstract][Full Text] [Related]
7. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
[TBL] [Abstract][Full Text] [Related]
8. Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study.
Freund-Levi Y; Vedin I; Hjorth E; Basun H; Faxén Irving G; Schultzberg M; Eriksdotter M; Palmblad J; Vessby B; Wahlund LO; Cederholm T; Basu S
J Alzheimers Dis; 2014; 42(3):823-31. PubMed ID: 24934544
[TBL] [Abstract][Full Text] [Related]
9. Effect of 8-week n-3 fatty-acid supplementation on oxidative stress and inflammation in middle- and long-distance running athletes: a pilot study.
Buonocore D; Verri M; Giolitto A; Doria E; Ghitti M; Dossena M
J Int Soc Sports Nutr; 2020 Nov; 17(1):55. PubMed ID: 33176827
[TBL] [Abstract][Full Text] [Related]
10. Effect of 6 Weeks of n-3 fatty-acid supplementation on oxidative stress in Judo athletes.
Filaire E; Massart A; Portier H; Rouveix M; Rosado F; Bage AS; Gobert M; Durand D
Int J Sport Nutr Exerc Metab; 2010 Dec; 20(6):496-506. PubMed ID: 21116022
[TBL] [Abstract][Full Text] [Related]
11. Effects of n-3 long-chain PUFA supplementation to lactating mothers and their breastfed children on child growth and morbidity: a 2 × 2 factorial randomized controlled trial in rural Ethiopia.
Argaw A; Wondafrash M; Bouckaert KP; Kolsteren P; Lachat C; Belachew T; De Meulenaer B; Huybregts L
Am J Clin Nutr; 2018 Mar; 107(3):454-464. PubMed ID: 29566189
[TBL] [Abstract][Full Text] [Related]
12. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
[TBL] [Abstract][Full Text] [Related]
13. Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.
Finocchiaro C; Segre O; Fadda M; Monge T; Scigliano M; Schena M; Tinivella M; Tiozzo E; Catalano MG; Pugliese M; Fortunati N; Aragno M; Muzio G; Maggiora M; Oraldi M; Canuto RA
Br J Nutr; 2012 Jul; 108(2):327-33. PubMed ID: 22114792
[TBL] [Abstract][Full Text] [Related]
14. n-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease.
Harving F; Svensson M; Flyvbjerg A; Schmidt EB; Jørgensen KA; Eriksen HH; Christensen JH
Clin Nephrol; 2015 May; 83(5):279-85. PubMed ID: 25816805
[TBL] [Abstract][Full Text] [Related]
15. Effects of omega-3 fatty acid supplementation on cigarette craving and oxidative stress index in heavy-smoker males: A double-blind, randomized, placebo-controlled clinical trial.
Sadeghi-Ardekani K; Haghighi M; Zarrin R
J Psychopharmacol; 2018 Sep; 32(9):995-1002. PubMed ID: 30136619
[TBL] [Abstract][Full Text] [Related]
16. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.
Daud ZA; Tubie B; Adams J; Quainton T; Osia R; Tubie S; Kaur D; Khosla P; Sheyman M
Vasc Health Risk Manag; 2012; 8():187-95. PubMed ID: 22536073
[TBL] [Abstract][Full Text] [Related]
17. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
18. n-3 polyunsaturated fatty acids do not alter immune and inflammation measures in endurance athletes.
Nieman DC; Henson DA; McAnulty SR; Jin F; Maxwell KR
Int J Sport Nutr Exerc Metab; 2009 Oct; 19(5):536-46. PubMed ID: 19910654
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F
Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
